ARCHIVES

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

April 29, 1988

Salick Signs contract for Fixed-Price Oncology Services

April 1, 1994

Study: Drug Discounts Used For Wealthier Patients In Many 340B-Enrolled Hospitals

October 10, 2014

Device Shortens Time To Make T Cells For Immunotherapy

March 27, 2009

In Brief: Freireich On Nutrition: Diet Can Affect Immune System, Effectiveness Of Cancer Drugs

September 12, 1975

Capitol Hill: Mammography Quality standards Act Reintroduced

April 18, 1997